MedTrace Logo

The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA

NCT05138289 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 258

Last updated 2025-08-22

Study results available
· View outcomes & findings →

Summary

This study will evaluate the level of agreement between noninvasive CCTA (coronary computed tomography angiography)-based quantification and characterization of coronary atherosclerosis and invasive IVUS (intravascular ultrasound).

Conditions

  • Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))

Interventions

OTHER

Total Plaque Volume

Compare total plaque volume with IVUS obtained during ICA (invasive coronary angiography)

Sponsors & Collaborators

  • HeartFlow, Inc.

    lead INDUSTRY

Principal Investigators

  • Jagat Narula, MD · HeartFlow Investigative Site

  • Thomas Stuckey, MD · HeartFlow Investigative site

  • Gaku Nakazawa, MD · HeartFlow investigative site

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-12
Primary Completion
2022-11-08
Completion
2022-11-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05138289 on ClinicalTrials.gov